These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2889345)

  • 1. Beta blockers and left ventricular hypertrophy in hypertension.
    Trimarco B; De Luca N; Cuocolo A; Ricciardelli B; Rosiello G; Lembo G; Volpe M
    Am Heart J; 1987 Oct; 114(4 Pt 2):975-83. PubMed ID: 2889345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regression of left ventricular hypertrophy with antihypertensive treatment].
    Galinier M; Bounhoure JP
    Presse Med; 1990 Nov; 19(37):1715-9. PubMed ID: 1979167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy: dissociation of structural and functional effects by therapy.
    Frohlich ED
    Adv Exp Med Biol; 1991; 308():175-90. PubMed ID: 1839347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.
    Trimarco B; De Luca N; Rosiello G; Ricciardelli B; Betocchi S; Filardi PP; Raponi M; Condorelli M
    Am J Cardiol; 1989 Oct; 64(12):745-51. PubMed ID: 2572165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.
    Frishman WH; Skolnick AE; Strom JA
    Circulation; 1989 Dec; 80(6 Suppl):IV151-61. PubMed ID: 2532080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical repair of hypertensive left ventricular remodeling.
    Motz WH; Scheler S; Strauer BE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of left ventricular hypertrophy following treatment with beta-blockers: experience with tertatolol.
    Trimarco B; Ricciardelli B; de Luca N; Cuocolo A; Volpe M; Lembo G; Condorelli M
    Am J Nephrol; 1986; 6 Suppl 2():94-9. PubMed ID: 2879479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy and systolic function in hypertensive patients during long-term treatment with ketanserin.
    Coto V; Cocozza M; Oliviero U; Lucariello A; Picano T; Castaldo B; Iovino V; Cacciatore L
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():77-80. PubMed ID: 2149516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
    Donohue TJ; Dworkin LD; Ma J; Lango MN; Catanese VM
    J Investig Med; 1997 Dec; 45(9):584-91. PubMed ID: 9444886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.
    Ram CV
    J Hypertens Suppl; 1989 Dec; 7(6):S98-9. PubMed ID: 2576672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; López B; Edner M; González A; Díez J; Malmqvist K
    J Hypertens; 2007 Sep; 25(9):1958-66. PubMed ID: 17762662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antihypertensive therapy on diastolic dysfunction in left ventricular hypertrophy.
    Betocchi S; Chiariello M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S116-21. PubMed ID: 1381787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy does not prevent heart failure in experimental hypertension.
    Hernán Gómez Llambí H; Cao G; Donato M; Suárez D; Ottaviano G; Müller A; Buchholz B; Gelpi R; Otero-Losada M; Milei J
    Int J Cardiol; 2017 Jul; 238():57-65. PubMed ID: 28410843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term antihypertensive treatment with tertatolol on diastolic function in hypertensive patients with and without left ventricular hypertrophy.
    Trimarco B; DeLuca N; Rosiello G; Ricciardelli B; Marchegiano R; Condorelli G; Raponi M; Condorelli M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):278S-283S. PubMed ID: 2573376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.
    Liebson PR
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):512-7. PubMed ID: 2142430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of increased left ventricular mass by antihypertensives.
    Lavie CJ; Ventura HO; Messerli FH
    Drugs; 1991 Dec; 42(6):945-61. PubMed ID: 1724641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.